Drug Trial Radar · NCT07911735
A Study Evaluating the Efficacy and Safety of SYH2072 Tablets In Hypertensive Patients
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
264
Planned (sponsor's estimate)
Start
Dec 13, 2026
Primary completion
Jul 22, 2027
Study completion Nov 28, 2027
Sponsor
- Lead sponsor
- InnovStone Therapeutics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Nov 3, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
SYH2072 is a highly selective aldosterone synthase inhibitor. This is a multicenter, randomized, double-blind, placebo-controlled Phase II study designed to evaluate the efficacy and safety of SYH2072 tablets in patients with uncontrolled hypertension (including patients with resistant hypertension) receiving stable treatment with two or more antihypertensive agents.
Conditions
- Uncontrolled Hypertension
- Resistant Hypertension
Interventions
SYH2072 TabletsDrug
Low-dose
SYH2072 TabletsDrug
Middle-dose
SYH2072 TabletsDrug
high-dose
placeboDrug
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in mean seated systolic blood pressure (msSBP)Time frame: at week 12
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.